Report Detail
Global Chronic Kidney Disease (CKD) Drugs Market Professional Survey Report 2019
- RnM3810088 |
- 09 October, 2019 |
- Global |
- 101 Pages |
- QYResearch |
- Pharma & Healthcare
Chronic Kidney Disease (CKD) Drugs are drugs for Chronic kidney disease, which also called chronic kidney failure, describes the gradual loss of kidney function.
Calcium channel blockers surfaced as the key drug class
The hospitals segment, which is the current market leader, is expected to continue its dominance in this market over the next few years.
The global Chronic Kidney Disease (CKD) Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Chronic Kidney Disease (CKD) Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Chronic Kidney Disease (CKD) Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Chronic Kidney Disease (CKD) Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Chronic Kidney Disease (CKD) Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Pfizer, Inc.
Amgen
Roche
GlaxoSmithKline (GSK)
Allergan
AbbVie
Kissei Pharmaceutical Co., Ltd.
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
ACE inhibitors
Angiotensin-II receptor blockers
Calcium channel blockers
Beta blockers: BREVIBLOC, Bystolic
Others
Segment by Application
Hospitals
Specialty Clinics
Table of Contents
Executive Summary
1 Industry Overview of Chronic Kidney Disease (CKD) Drugs
- 1.1 Definition of Chronic Kidney Disease (CKD) Drugs
- 1.2 Chronic Kidney Disease (CKD) Drugs Segment by Type
- 1.2.1 Global Chronic Kidney Disease (CKD) Drugs Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 ACE inhibitors
- 1.2.3 Angiotensin-II receptor blockers
- 1.2.4 Calcium channel blockers
- 1.2.5 Beta blockers: BREVIBLOC, Bystolic
- 1.2.6 Others
- 1.3 Chronic Kidney Disease (CKD) Drugs Segment by Applications
- 1.3.1 Global Chronic Kidney Disease (CKD) Drugs Consumption Comparison by Applications (2014-2025)
- 1.3.2 Hospitals
- 1.3.3 Specialty Clinics
- 1.4 Global Chronic Kidney Disease (CKD) Drugs Overall Market
- 1.4.1 Global Chronic Kidney Disease (CKD) Drugs Revenue (2014-2025)
- 1.4.2 Global Chronic Kidney Disease (CKD) Drugs Production (2014-2025)
- 1.4.3 North America Chronic Kidney Disease (CKD) Drugs Status and Prospect (2014-2025)
- 1.4.4 Europe Chronic Kidney Disease (CKD) Drugs Status and Prospect (2014-2025)
- 1.4.5 China Chronic Kidney Disease (CKD) Drugs Status and Prospect (2014-2025)
- 1.4.6 Japan Chronic Kidney Disease (CKD) Drugs Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Chronic Kidney Disease (CKD) Drugs Status and Prospect (2014-2025)
- 1.4.8 India Chronic Kidney Disease (CKD) Drugs Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Chronic Kidney Disease (CKD) Drugs
- 2.3 Manufacturing Process Analysis of Chronic Kidney Disease (CKD) Drugs
- 2.4 Industry Chain Structure of Chronic Kidney Disease (CKD) Drugs
3 Development and Manufacturing Plants Analysis of Chronic Kidney Disease (CKD) Drugs
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Chronic Kidney Disease (CKD) Drugs Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Chronic Kidney Disease (CKD) Drugs
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Chronic Kidney Disease (CKD) Drugs Production and Capacity Analysis
- 4.2 Chronic Kidney Disease (CKD) Drugs Revenue Analysis
- 4.3 Chronic Kidney Disease (CKD) Drugs Price Analysis
- 4.4 Market Concentration Degree
5 Chronic Kidney Disease (CKD) Drugs Regional Market Analysis
- 5.1 Chronic Kidney Disease (CKD) Drugs Production by Regions
- 5.1.1 Global Chronic Kidney Disease (CKD) Drugs Production by Regions
- 5.1.2 Global Chronic Kidney Disease (CKD) Drugs Revenue by Regions
- 5.2 Chronic Kidney Disease (CKD) Drugs Consumption by Regions
- 5.3 North America Chronic Kidney Disease (CKD) Drugs Market Analysis
- 5.3.1 North America Chronic Kidney Disease (CKD) Drugs Production
- 5.3.2 North America Chronic Kidney Disease (CKD) Drugs Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Chronic Kidney Disease (CKD) Drugs Import and Export
- 5.4 Europe Chronic Kidney Disease (CKD) Drugs Market Analysis
- 5.4.1 Europe Chronic Kidney Disease (CKD) Drugs Production
- 5.4.2 Europe Chronic Kidney Disease (CKD) Drugs Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Chronic Kidney Disease (CKD) Drugs Import and Export
- 5.5 China Chronic Kidney Disease (CKD) Drugs Market Analysis
- 5.5.1 China Chronic Kidney Disease (CKD) Drugs Production
- 5.5.2 China Chronic Kidney Disease (CKD) Drugs Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Chronic Kidney Disease (CKD) Drugs Import and Export
- 5.6 Japan Chronic Kidney Disease (CKD) Drugs Market Analysis
- 5.6.1 Japan Chronic Kidney Disease (CKD) Drugs Production
- 5.6.2 Japan Chronic Kidney Disease (CKD) Drugs Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Chronic Kidney Disease (CKD) Drugs Import and Export
- 5.7 Southeast Asia Chronic Kidney Disease (CKD) Drugs Market Analysis
- 5.7.1 Southeast Asia Chronic Kidney Disease (CKD) Drugs Production
- 5.7.2 Southeast Asia Chronic Kidney Disease (CKD) Drugs Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Chronic Kidney Disease (CKD) Drugs Import and Export
- 5.8 India Chronic Kidney Disease (CKD) Drugs Market Analysis
- 5.8.1 India Chronic Kidney Disease (CKD) Drugs Production
- 5.8.2 India Chronic Kidney Disease (CKD) Drugs Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Chronic Kidney Disease (CKD) Drugs Import and Export
6 Chronic Kidney Disease (CKD) Drugs Segment Market Analysis (by Type)
- 6.1 Global Chronic Kidney Disease (CKD) Drugs Production by Type
- 6.2 Global Chronic Kidney Disease (CKD) Drugs Revenue by Type
- 6.3 Chronic Kidney Disease (CKD) Drugs Price by Type
7 Chronic Kidney Disease (CKD) Drugs Segment Market Analysis (by Application)
- 7.1 Global Chronic Kidney Disease (CKD) Drugs Consumption by Application
- 7.2 Global Chronic Kidney Disease (CKD) Drugs Consumption Market Share by Application (2014-2019)
8 Chronic Kidney Disease (CKD) Drugs Major Manufacturers Analysis
- 8.1 Pfizer, Inc.
- 8.1.1 Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs Production Sites and Area Served
- 8.1.2 Pfizer, Inc. Product Introduction, Application and Specification
- 8.1.3 Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Amgen
- 8.2.1 Amgen Chronic Kidney Disease (CKD) Drugs Production Sites and Area Served
- 8.2.2 Amgen Product Introduction, Application and Specification
- 8.2.3 Amgen Chronic Kidney Disease (CKD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Roche
- 8.3.1 Roche Chronic Kidney Disease (CKD) Drugs Production Sites and Area Served
- 8.3.2 Roche Product Introduction, Application and Specification
- 8.3.3 Roche Chronic Kidney Disease (CKD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 GlaxoSmithKline (GSK)
- 8.4.1 GlaxoSmithKline (GSK) Chronic Kidney Disease (CKD) Drugs Production Sites and Area Served
- 8.4.2 GlaxoSmithKline (GSK) Product Introduction, Application and Specification
- 8.4.3 GlaxoSmithKline (GSK) Chronic Kidney Disease (CKD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Allergan
- 8.5.1 Allergan Chronic Kidney Disease (CKD) Drugs Production Sites and Area Served
- 8.5.2 Allergan Product Introduction, Application and Specification
- 8.5.3 Allergan Chronic Kidney Disease (CKD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 AbbVie
- 8.6.1 AbbVie Chronic Kidney Disease (CKD) Drugs Production Sites and Area Served
- 8.6.2 AbbVie Product Introduction, Application and Specification
- 8.6.3 AbbVie Chronic Kidney Disease (CKD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Kissei Pharmaceutical Co., Ltd.
- 8.7.1 Kissei Pharmaceutical Co., Ltd. Chronic Kidney Disease (CKD) Drugs Production Sites and Area Served
- 8.7.2 Kissei Pharmaceutical Co., Ltd. Product Introduction, Application and Specification
- 8.7.3 Kissei Pharmaceutical Co., Ltd. Chronic Kidney Disease (CKD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
9 Development Trend of Analysis of Chronic Kidney Disease (CKD) Drugs Market
- 9.1 Global Chronic Kidney Disease (CKD) Drugs Market Trend Analysis
- 9.1.1 Global Chronic Kidney Disease (CKD) Drugs Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Chronic Kidney Disease (CKD) Drugs Regional Market Trend
- 9.2.1 North America Chronic Kidney Disease (CKD) Drugs Forecast 2019-2025
- 9.2.2 Europe Chronic Kidney Disease (CKD) Drugs Forecast 2019-2025
- 9.2.3 China Chronic Kidney Disease (CKD) Drugs Forecast 2019-2025
- 9.2.4 Japan Chronic Kidney Disease (CKD) Drugs Forecast 2019-2025
- 9.2.5 Southeast Asia Chronic Kidney Disease (CKD) Drugs Forecast 2019-2025
- 9.2.6 India Chronic Kidney Disease (CKD) Drugs Forecast 2019-2025
- 9.3 Chronic Kidney Disease (CKD) Drugs Market Trend (Product Type)
- 9.4 Chronic Kidney Disease (CKD) Drugs Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Chronic Kidney Disease (CKD) Drugs Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Chronic Kidney Disease (CKD) Drugs. Industry analysis & Market Report on Chronic Kidney Disease (CKD) Drugs is a syndicated market report, published as Global Chronic Kidney Disease (CKD) Drugs Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Chronic Kidney Disease (CKD) Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
